Messenger RNA Synthesis Research Articles

ROLES OF SCAP (STEROL REGULATORY ELEMENT–BINDING PROTEIN CLEAVAGE-ACTIVATING PROTEIN) IN THE MECHANISM FOR MESANGIAL FOAM-CELL FORMATION UNDER INFLAMMATORY STRESS

INTRODUCTION: Our previous studies have demonstrated that lipid abnormalities play a significant role in glomerulosclerosis. Inflammatory cytokines promote lipid accumulation in human mesangial cells (HMCLs) by disrupting low-density lipoprotein receptor (LDLr) feedback regulation. The sterol regulatory element–binding protein (SREBP) cleavage-activating protein (SCAP) carries SREBP from endoplasmic reticulum (ER) to Golgi, where it is known to cleave SREBP, thereby enhancing LDLr gene expression and cholesterol uptake when cells need cholesterol. OBJECTIVE: We aimed to investigate whether inflammatory mediators interfere with SCAP translocation and its biological consequence. METHODS: HMCLs were used in all experiments. Total cellular RNA was isolated from these cells for detecting LDLr, SREBP-2, and SCAP messenger RNA levels with real-time quantitative polymerase chain reaction. LDLr protein expression was measured by Western blot. Translocation of the SCAP-SREBP complex from the ER to Golgi was investigated by confocal microscopy. RESULTS: In the absence of exposure to interleukin 1β, a high concentration of LDL retained SCAP in the ER, a low LDLr promoter activity, messenger RNA synthesis, and protein expression were found, respectively. However, exposure to interleukin 1β caused overexpression of SCAP and enhanced its translocation from the ER to Golgi. This disrupted normal feedback regulation and resulted in inappropriately increased LDL uptake with transformation of HMCLs into foam cells. Overexpression of SCAP in HMCLs resulted in an increased translocation of SCAP from the ER to Golgi, and high concentrations of LDL were unable to suppress SREBP-2 and LDLr gene expression. CONCLUSIONS: These data suggest that inflammatory mediators promote abnormal translocation of SCAP from the ER to Golgi and play an important role in lipid accumulation in HMCLs.

Stochastic gene expression out-of-steady-state in the cyanobacterial circadian clock

Recent advances in measuring gene expression at the single-cell level have highlighted the stochastic nature of messenger RNA and protein synthesis. Stochastic gene expression creates a source of variability in the abundance of cellular components, even among isogenic cells exposed to an identical environment. Recent integrated experimental and modelling studies have shed light on the molecular sources of this variability. However, many of these studies focus on systems that have reached a steady state and therefore do not address a large class of dynamic phenomena including oscillatory gene expression. Here we develop a general protocol for analysing and predicting stochastic gene expression in systems that never reach steady states. We use this framework to analyse experimentally stochastic expression of genes driven by the Synechococcus elongatus circadian clock. We find that, although the average expression at two points in the circadian cycle separated by 12 hours is identical, the variability at these two time points can be different. We show that this is a general feature of out-of-steady-state systems. We demonstrate how intrinsic noise sources, owing to random births and deaths of mRNAs and proteins, or extrinsic noise sources, which introduce fluctuations in rate constants, affect the cell-to-cell variability. To distinguish experimentally between these sources, we measured how the correlation between expression fluctuations of two identical genes is modulated during the circadian cycle. This quantitative framework is generally applicable to any out-of-steady-state system and will be necessary for understanding the fidelity of dynamic cellular systems.

Toward a High-Resolution View of Nuclear Dynamics

The nucleus is the defining feature of eukaryotic cells. It is a highly dynamic, membrane-bound organelle that encloses chromatin and thereby partitions gene transcription from sites of protein translation in the cytoplasm. Major cellular events, including DNA replication, messenger RNA synthesis and processing, and ribosome subunit biogenesis, take place within the nucleus, resulting in a continuous flux of macromolecules into and out of the nucleus through dedicated nuclear pore complexes in the nuclear envelope. Here, we review the impact of new technologies, especially in areas of fluorescence microscopy and proteomics, which are providing major insights into dynamic processes affecting both structure and function within the nucleus.

Insights in the regulation of cholesterol 7α-hydroxylase gene reveal a target for modulating bile acid synthesis

The transcription of the gene (CYP7A1) encoding cholesterol 7alpha-hydroxylase, a key enzyme in cholesterol homeostasis, is repressed by bile acids via multiple mechanisms involving members of the nuclear receptor superfamily. Here, we describe a regulatory mechanism that can be exploited for modulating bile acid synthesis. By dissecting the mechanisms of CYP7A1 transcription, we found that bile acids stimulate the sequential recruitment of the histone deacetylases (HDACs) 7, 3, and 1, and of the corepressor SMRTalpha (silencing mediator of retinoid and thyroid receptors-alpha) and the nuclear corepressor. Bile acids, but not the farnesoid X receptor-selective agonist GW4064, increase the nuclear concentration of HDAC7, which promotes the assembly of a repressive complex that ultimately represses CYP7A1 transcription. Interestingly, despite its high basal expression level, small heterodimer partner (SHP) is associated with the CYP7A1 promoter only at a later stage of bile acid repression. Gene silencing with small interfering RNA confirms that HDAC7 is the key factor required for the repression of CYP7A1 transcription, whereas knockdown of SHP does not prevent the down-regulation of CYP7A1. Administration of the HDAC inhibitors valproic acid or trichostatin A to genetically hypercholesterolemic mice increases Cyp7a1 messenger RNA and bile acid synthesis and consequently markedly reduces total plasma and low-density lipoprotein cholesterol. By using a combination of molecular, cellular, and animal models, our study highlights the importance of HDACs in the feedback regulation of CYP7A1 transcription and identifies these enzymes as potential targets to modulate bile acid synthesis and for the treatment of hypercholesterolemia.

Calcium Restores Prepenetration Morphogenesis Abolished by Methylglyoxal-Bis-Guanyl Hydrazone inCochliobolus miyabeanusInfecting Rice

ABSTRACT Cochliobolus miyabeanus forms a specialized infection structure, an appressorium, to infect its host rice plants. Curtailment of prepenetration development by spermidine and spermine was more evident in appressorium development and germination remained unaffected, whereas putrescine and methylglyoxal-bis-guanyl hydrazone (MGBG) impaired both morphogenetic events. Exogenous calcium nullified the inhibitory effect of MGBG on the prepenetration development in vitro and in vivo and the disease progression. High levels of polyamines were detected in freshly collected conidia, but the amounts were reduced during germination and appressorium formation. MGBG fortified the decrease of polyamines within conidia under development and calcium amendment did not affect the reduction. Hard-surface contact augmented messenger RNA synthesis of calmodulin gene (CmCaM) and protein kinase C (PKC) activity in germinating or appressorium-forming conidia. Calcium restored transcription of CmCaM and upregulation of PKC activity suppressed by MGBG. Taken together, fine-tuning of intracellular polyamine transition is indispensable for the conidial germination and appressorium formation in C. miyabeanus. Biochemical and molecular analyses revealed that the MGBG-acting site or sites are upstream of Ca(2+)-dependent signaling pathways regulating prepenetration morphogenesis of C. miyabeanus causing rice brown leaf spot.

Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells

Previous studies in our laboratory showed a dose-dependent and hormone-specific increase in CD154 expression in T cells from females with systemic lupus erythematosus (SLE). This present study investigates if the estrogen-dependent increase in CD154 expression is due to stabilization of the messenger RNA. T cells from female SLE patients and controls were cultured for 18 h in serum-free medium without and with estradiol 17-beta (10(-7) M). T cells were either unstimulated (resting) or were activated by further culture on anti-CD3 coated plates. Actinomycin D (25 microg/mL) was added to parallel cultures to inhibit new messenger RNA synthesis. CD154 messenger RNA stability was assessed by reverse-transcription polymerase chain amplification. Resting SLE (n = 10, P = 0.88) and normal (n = 7, P = 0.65) T cells showed no significant differences in message stability in response to estradiol. CD154 messenger RNA was also not significantly stabilized in activated SLE (n = 10, P = 0.15) or activated normal (n = 6, P = 0.077) T cells in response to estradiol. These findings indicate that the estrogen-dependent increase in CD154 in SLE T cells is not due to stability of the mRNA. These data are consistent with the postulate that estradiol stimulates CD154 transcription in SLE T cells.

Cdk9 is an essential kinase in Drosophila that is required for heat shock gene expression, histone methylation and elongation factor recruitment

Phosphorylation of the large RNA Polymerase II subunit C-terminal domain (CTD) is believed to be important in promoter clearance and for recruiting protein factors that function in messenger RNA synthesis and processing. P-TEFb is a protein kinase that targets the (CTD). The goal of this study was to identify chromatin modifications and associations that require P-TEFb activity in vivo. We knocked down the catalytic subunit of P-TEFb, Cdk9, in Drosophila melanogaster using RNA interference. Cdk9 knockdown flies die during metamorphosis. Phosphorylation at serine 2 and serine 5 of the CTD heptad repeat were both dramatically reduced in knockdown larvae. Hsp 70 mRNA induction by heat shock was attenuated in Cdk9 knockdown larvae. Both mono- and trimethylation of histone H3 at lysine 4 were dramatically reduced, suggesting a link between CTD phosphorylation and histone methylation in transcribed chromatin in vivo. Levels of the chromo helicase protein CHD1 were reduced in Cdk9 knockdown chromosomes, suggesting that CHD1 is targeted to chromosomes through P-TEFb-dependent histone methylation. Dimethylation of histone H3 at lysine 36 was significantly reduced in knockdown larvae, implicating CTD phosphorylation in the regulation of this chromatin modification. Binding of the RNA Polymerase II elongation factor ELL was reduced in knockdown chromosomes, suggesting that ELL is recruited to active polymerase via CTD phosphorylation.

Transcriptional blackjack with p21: Figure 1.

Transcriptional regulation by RNA polymerase II (RNA Pol II) is an amalgamated process requiring the collective action of a large number of transcription factors to ensure proper synthesis of messenger RNA (mRNA). Several RNA Pol II elongation factors and proper phosphorylation of the C-terminal domain (CTD) of the RPB1 subunit of Pol II have been shown to be essential for transcription when RNA Pol II enters its processive elongation stage. In a study reported in the previous issue of Genes & Development, Emerson and colleagues (Gomes et al. 2006) demonstrated an exception to this rule. Transcription of p21, a target gene within the p53 pathway, bypasses the requirements for RNA Pol II elongation factors (including P-TEFb) and CTD phosphorylation for its p53-dependent transcription. Their data indicate the presence of a cellular compensatory mechanism for several of the p53 target genes to ensure a transcriptional response under heightened cellular stress. Mammalian cells are bombarded with a host of cellular stresses and require specialized mechanisms to maintain their integrity. The p53 protein is a sequence-specific DNA-binding transcription factor that regulates expression of numerous genes involved in cell cycle arrest and apoptosis, and is regarded as the cell’s cornerstone of defense against stresses such as DNA damage, oncogene activation, and oxidative stress (Takimoto and El-Deiry 2001; Taylor and Stark 2001). Several genes involved in the DNA damage response pathway contain p53-binding elements upstream of their promoters. In response to chemical or irradiation-induced DNA damage, binding of p53 to target genes occurs rapidly to shut off cell cycle progression and allow for recovery. There are a variety of p53-dependent pathways that can maintain cell cycle blocks (Bunz et al. 1998; Agami and Bernards 2000; Laronga et al. 2000; Vousden 2000; Gartel and Tyner 2002). Induction of cell cycle arrest by p53 is regulated by the level of transcriptional activation of the p21/WAF1/CIP1 gene (Espinosa and Emerson 2001; Takimoto and El-Deiry 2001; Espinosa et al. 2003). Once p21 (a potent inhibitor of cyclindependent kinases) is expressed, the cells become arrested (Agami and Bernards 2000). The topoisomerase II inhibitor doxorubicin induces double-stranded DNA breaks and is also a potent stimulator of p53 activity (Ravizza et al. 2004). The results presented by Gomes et al. (2006) in the previous issue of Genes & Development give new insight into the complicated mechanisms cells use to respond to various stresses, and strongly suggest the existence of highly specialized cellular responses that are specific for each type of stress-inducing factor.

Dendritic mRNAs encode diversified functionalities in hippocampal pyramidal neurons

BackgroundTargeted transport of messenger RNA and local protein synthesis near the synapse are important for synaptic plasticity. In order to gain an overview of the composition of the dendritic mRNA pool, we dissected out stratum radiatum (dendritic lamina) from rat hippocampal CA1 region and compared its mRNA content with that of stratum pyramidale (cell body layer) using a set of cDNA microarrays. RNAs that have over-representation in the dendritic fraction were annotated and sorted into function groups.ResultsWe have identified 154 dendritic mRNA candidates, which can be arranged into the categories of receptors and channels, signaling molecules, cytoskeleton and adhesion molecules, and factors that are involved in membrane trafficking, in protein synthesis, in posttranslational protein modification, and in protein degradation. Previously known dendritic mRNAs such as MAP2, calmodulin, and G protein gamma subunit were identified from our screening, as were mRNAs that encode proteins known to be important for synaptic plasticity and memory, such as spinophilin, Pumilio, eEF1A, and MHC class I molecules. Furthermore, mRNAs coding for ribosomal proteins were also found in dendrites.ConclusionOur results suggest that neurons transport a variety of mRNAs to dendrites, not only those directly involved in modulating synaptic plasticity, but also others that play more common roles in cellular metabolism.

The formation of auditory fear memory requires the synthesis of protein and mRNA in the auditory thalamus

The medial geniculate nucleus of the thalamus responds to auditory information and is a critical part of the neural circuitry underlying aversive conditioning with auditory signals for shock. Prior work has shown that lesions of this brain area selectively disrupt conditioning with auditory stimuli and that neurons in the medial geniculate demonstrate plastic changes during fear conditioning. However, recent evidence is less clear as to whether or not this area plays a role in the storage of auditory fear memories. In the current set of experiments rats were given infusions of protein or messenger RNA (mRNA) synthesis inhibitors into the medial geniculate nucleus of the thalamus 30 min prior to auditory fear conditioning. The next day animals were tested to the auditory cue and conditioning context. Results showed that rats infused with either inhibitor demonstrated less freezing to the auditory cue 24 h after training, while freezing to the context was normal. Autoradiography confirmed that the doses used were effective in disrupting synthesis. Taken together with prior work, these data suggest that the formation of fear memory requires the synthesis of new protein and mRNA at multiple brain sites across the neural circuit that supports fear conditioning.

Regulation of matrix metalloproteinase expression by dynamic tensile strain in rat fibrochondrocytes

We sought to determine the molecular basis for the anticatabolic effects of mechanical signals on fibrocartilage cells by studying the expression of a variety of matrix metalloproteinases (MMPs). Furthermore, we examined whether the effects of biomechanical strain on MMP gene expression are sustained. Fibrochondrocytes from temporomandibular joint (TMJ) discs were exposed to dynamic tensile strain for various time intervals in the presence of interleukin (IL)-1beta. The regulation of the messenger RNA (mRNA) expression and synthesis of MMPs and tissue inhibitors of MMPs (TIMPs) were examined by end-point and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) as well as Western blot analysis. Fibrochondrocytes expressed mRNA for MMP-2, -3, -7, -8, -9, -11, -13, -14, -16, -17, and -19 as well as TIMP-1, -2, and -3, IL-1beta induced a significant (P<0.05) upregulation of mRNA for MMP-3, -7, -8, -9, -13, -16, -17, and -19. The IL-1beta-stimulated upregulation of these MMPs was significantly (P<0.05) abrogated by dynamic tensile strain. However, MMP-2, -11, -14, and TIMPs were not affected by either IL-1beta or tensile strain. Biomechanical strain also inhibited the IL-1beta-stimulated protein synthesis of MMP-3, -7, -8, -9, -13, -16, and -17. Application of mechanical strain for various time intervals during a 24-h incubation with IL-1beta showed that the suppressive effects of mechanical signals are sustained. The data provide evidence that biomechanical signals can downregulate the catabolic activity of fibrocartilage cells in an inflammatory environment by inhibiting the expression of a variety of MMPs. Furthermore, the matrix-protective effects of biomechanical signals are sustained even in an inflammatory environment.

C-C Chemokine Ligand 2 Gene Expression in Nasal Polyp Fibroblasts: Possible Implication in the Pathogenesis of Nasal Polyposis

Recruitment of macrophages is essential to the pathogenesis of nasal polyps (NP), since this disease is inflammation-related. In this study, the effects of tumor necrosis factor alpha (TNF-alpha) on the expression of C-C chemokine ligand 2 (CCL2) in fibroblasts derived from nasal polyps (NPFs) were investigated. The roles of cyclooxygenase (COX) 2 and prostaglandins in the mediation of TNF-alpha-stimulated CCL2 gene expression were also investigated. Northern blot analysis was used to study the expression of CCL2 and c-Fos in cultured NPFs. An electrophoretic mobility shift assay was used to explore the interactions between activator protein 1 (AP- 1) and DNA. Immunohistochemistry was used to explore the in vivo expressions of COX-2, CCL2, and CD68 in NPs. The Northern blot analysis showed that TNF-alpha stimulated the expression of CCL2 and COX-2 genes, and the synthesis of CCL2 messenger RNA was COX-2-dependent. A transient elevation of c-Fos and c-Jun messenger RNAs was induced by TNF-alpha, whereas COX-2 inhibitors NS-398 and meloxicam abolished the up-regulation of c-Fos. The electrophoretic mobility shift assay revealed that TNF-alpha triggered AP-1 and DNA binding and again, NS-398 and meloxicam inhibited this reaction via reducing c-Fos synthesis. Curcumin (AP-1 inhibitor) markedly suppressed the TNF-alpha-induced CCL2 expression. The immunohistochemical staining of NP surgical specimens also revealed an intimate alignment between CCL2-positive fibroblasts and CD-68-positive macrophages. These data suggest that NPFs may contribute to NP development by synthesizing CCL2 to promote macrophage recruitment. Furthermore, COX-2 facilitates CCL2 transcription in NPFs via a c-Fos and AP-1 signaling pathway.

The absence of CD20 messenger RNA in recurrent cutaneous B‐cell lymphoma following rituximab therapy

Rituximab has been used to treat relapsed low-grade or advanced non-Hodgkin's lymphoma since 1997, targeting the CD20 antigen expressed by B cells. Single-agent rituximab therapy is safe and well tolerated. Recurrences showing a loss of CD20 expression following rituximab therapy have been reported. Four patients with CD20-positive cutaneous B-cell lymphoma received rituximab therapy with subsequent recurrences. The biopsies were assessed for cytoplasmic CD20 expression; CD20 messenger RNA was also assessed where tissue was available. Cutaneous relapses occurring within 1.5-3 months following the last dose of rituximab were CD20 negative. In three cases, subsequent relapses showed renewed expression of CD20. Those biopsies demonstrating a loss of surface and cytoplasmic CD20 by immunohistochemistry also showed no evidence of messenger RNA for CD20 using an in situ polymerase chain reaction-based methodology. Rituximab may be associated with the emergence of CD20-negative B-cell clones, potentially rendering a tumor insensitive to this drug. Conversely, following cessation of the drug, a re-expression of CD20 within the neoplastic cells may occur allowing therapeutic intervention with this monoclonal antibody. The loss of CD20 expression appears to be a direct effect of the drug on CD20 messenger RNA synthesis.

The perichromosomal layer

In addition to genetic information, mitotic chromosomes transmit essential components for nuclear assembly and function in a new cell cycle. A specialized chromosome domain, called the perichromosomal layer, perichromosomal sheath, chromosomal coat, or chromosome surface domain, contains proteins required for a variety of cellular processes, including the synthesis of messenger RNA, assembly of ribosomes, repair of DNA double-strand breaks, telomere maintenance, and apoptosis regulation. The layer also contains many proteins of unknown function and is a major target in autoimmune disease. Perichromosomal proteins are found along the entire length of chromosomes, excluding centromeres, where sister chromatids are paired and spindle microtubules attach. Targeting of proteins to the perichromosomal layer occurs primarily during prophase, and they generally remain associated until telophase. During interphase, perichromosomal proteins localize to nucleoli, the nuclear envelope, nucleoplasm, heterochromatin, centromeres, telomeres, and/or the cytoplasm. It has been suggested that the perichromosomal layer may contribute to chromosome structure, as several of the associated proteins have functions in chromatin remodeling during interphase. We review the identified proteins associated with this chromosome domain and briefly discuss their known functions during interphase and mitosis.

Transcription of mammalian messenger RNAs by a nuclear RNA polymerase of mitochondrial origin

Transcription of eukaryotic genes is performed by three nuclear RNA polymerases, of which RNA polymerase II is thought to be solely responsible for the synthesis of messenger RNAs. Here we show that transcription of some mRNAs in humans and rodents is mediated by a previously unknown single-polypeptide nuclear RNA polymerase (spRNAP-IV). spRNAP-IV is expressed from an alternative transcript of the mitochondrial RNA polymerase gene (POLRMT). The spRNAP-IV lacks 262 amino-terminal amino acids of mitochondrial RNA polymerase, including the mitochondrial-targeting signal, and localizes to the nucleus. Transcription by spRNAP-IV is resistant to the RNA polymease II inhibitor alpha-amanitin but is sensitive to short interfering RNA specific for the POLRMT gene. The promoters for spRNAP-IV differ substantially from those used by RNA polymerase II, do not respond to transcriptional enhancers and contain a common functional sequence motif.

Transforming Growth Factor-β&lt;sub&gt;3&lt;/sub&gt; Induces Pleurodesis in Rabbits and Collagen Production of Human Mesothelial Cells&lt;xref rid="AFF1"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/xref&gt;

The aim of this study was to examined whether transforming growth factor (TGF)-beta(3) induces pleurodesis in rabbits and collagen production by human pleural mesothelial cells in vitro. A combined animal and in vitro study. TGF-beta(3) was injected intrapleurally in rabbits at the following doses: 0.167 mug, 0.5 mug, 1.67 mug, and 5 mug (five rabbits per group). The rabbits were killed 14 days following injection, and pleurodesis was graded from 1 (none) to 8 (complete symphysis). Pleural mesothelial cell cultures were established from benign pleural effusions and treated with TGF-beta(3) for 48 h at the following doses: 0 (control), 5 ng/mL, 1.5 ng/mL, 5 ng/mL, and 15 ng/mL and 50 ng/mL (two independent experiments). Collagen I messenger RNA (mRNA) expression was quantified using real-time polymerase chain reaction. The median pleurodesis score was 5 (interquartile range [IQR], 4.5) in the 0.167-mug group, 6 (IQR, 5) in the 0.5-mug group, 8 (IQR, 1) in the 1.67-mug group, and 8 (IQR, 0.5) in the 5-mug group (p = 0.012). Higher TGF-beta(3) doses induced the production of significantly more pleural fluid than the lower doses (p = 0.005). The pleural fluid induced by higher doses contained significantly lower numbers of nucleated cells (p = 0.014) and lactate dehydrogenase levels (p = 0.013) than the pleural fluid induced by lower doses of the agent. TGF-beta(3) markedly enhanced collagen I mRNA expression by the human pleural mesothelial cells. This effect peaked at 5 ng/mL TGF-beta(3). With this dose of TGF-beta(3), the collagen I mRNA expression was increased 16-fold over control levels. TGF-beta(3) causes a dose-dependent pleurodesis when administered intrapleurally in rabbits, and induces collagen messenger RNA synthesis from human pleural mesothelial cells.

Transforming Growth Factor-β3 Induces Pleurodesis in Rabbits and Collagen Production of Human Mesothelial Cells

Study objective The aim of this study was to examined whether transforming growth factor (TGF)-β 3 induces pleurodesis in rabbits and collagen production by human pleural mesothelial cells in vitro Design A combined animal and in vitro study Methods TGF-β 3 was injected intrapleurally in rabbits at the following doses: 0.167 μg, 0.5 μg, 1.67 μg, and 5 μg (five rabbits per group). The rabbits were killed 14 days following injection, and pleurodesis was graded from 1 (none) to 8 (complete symphysis). Pleural mesothelial cell cultures were established from benign pleural effusions and treated with TGF-β 3 for 48 h at the following doses: 0 (control), 5 ng/mL, 1.5 ng/mL, 5 ng/mL, and 15 ng/mL and 50 ng/mL (two independent experiments). Collagen I messenger RNA (mRNA) expression was quantified using real-time polymerase chain reaction Results The median pleurodesis score was 5 (interquartile range [IQR], 4.5) in the 0.167-μg group, 6 (IQR, 5) in the 0.5-μg group, 8 (IQR, 1) in the 1.67-μg group, and 8 (IQR, 0.5) in the 5-μg group (p = 0.012). Higher TGF-β 3 doses induced the production of significantly more pleural fluid than the lower doses (p = 0.005). The pleural fluid induced by higher doses contained significantly lower numbers of nucleated cells (p = 0.014) and lactate dehydrogenase levels (p = 0.013) than the pleural fluid induced by lower doses of the agent. TGF-β 3 markedly enhanced collagen I mRNA expression by the human pleural mesothelial cells. This effect peaked at 5 ng/mL TGF-β 3 . With this dose of TGF-β 3 , the collagen I mRNA expression was increased 16-fold over control levels Conclusion TGF-β 3 causes a dose-dependent pleurodesis when administered intrapleurally in rabbits, and induces collagen messenger RNA synthesis from human pleural mesothelial cells

Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s disease

T-helper (Th)1 cells play a central role in the pathogenesis of tissue damage in Crohn's disease (CD). Interleukin (IL)-12/STAT4 signaling promotes Th1 cell commitment in CD, but other cytokines are needed to maintain activated Th1 cells in the mucosa. In this study, we examined the expression and role of IL-21, a T-cell-derived cytokine of the IL-2 family; in tissues and cells isolated from patients with inflammatory bowel disease. IL-21 was examined by Western blotting in whole mucosa and lamina propria mononuclear cells (LPMCs) from patients with CD, ulcerative colitis (UC), and controls. We also examined the effects of exogenous IL-12 on IL-21 production, as well as the effects of blocking IL-21 with an IL-21-receptor Ig fusion protein. Interferon (IFN)-gamma was measured in the culture supernatants by enzyme-linked immunosorbent assay, and phosphorylated STAT4 and T-bet were examined by Western blotting. IL-21 was detected in all samples, but its expression was higher at the site of disease in CD in comparison with UC and controls. Enhanced IL-21 was seen in both ileal and colonic CD and in fibrostenosing and nonfibrostenosing disease. IL-12 enhanced IL-21 in normal lamina propria lymphocytes through an IFN-gamma-independent mechanism, and blocking IL-12 in CD LPMCs decreased anti-CD3-stimulated IL-21 expression. Neutralization of IL-21 in CD LPMC cultures decreased phosphorylated STAT4 and T-bet expression, thereby inhibiting IFN-gamma production. Our data suggest that IL-21 contributes to the ongoing Th1 mucosal response in CD.

Biochemical mechanisms for translational regulation in synaptic plasticity

Changes in gene expression are required for long-lasting synaptic plasticity and long-term memory in both invertebrates and vertebrates. Regulation of local protein synthesis allows synapses to control synaptic strength independently of messenger RNA synthesis in the cell body. Recent reports indicate that several biochemical signalling cascades couple neurotransmitter and neurotrophin receptors to translational regulatory factors in protein synthesis-dependent forms of synaptic plasticity and memory. In this review, we highlight these translational regulatory mechanisms and the signalling pathways that govern the expression of synaptic plasticity in response to specific types of neuronal stimulation.

The genetics of deafness

Deafness has many recognized genetic and environmental causes. Nearly 400 forms of deafness have been identified in which the presence of associated clinical findings permits the diagnosis of a specific form of syndromic deafness. About 70–80% of genetic deafness is nonsyndromic. Molecular and histologic studies of messenger RNA (mRNA) synthesis have allowed the developmental stage, tissues, and cells in which these genes are expressed to be determined, resulting in an ever more detailed understanding of the molecular basis of hearing. Several large classes of proteins are known that are typically required to initiate the transcription of mRNA. Advances in human genetics have posed many ethical questions, related to such areas as privacy, autonomy, prenatal diagnosis, stem cell research, and the rights of children. Alexander Graham Bell's involvement with the eugenics movement may have had a lasting influence on the attitudes of the deaf community toward genetics.